Icon8888 Gossips About Stocks

(Icon) Consumer Products - CCK Consolidated, CCM Duopharma, Chee Wah Corp

Icon8888
Publish date: Mon, 09 Feb 2015, 10:19 AM
Icon8888
0 404
I follow the smell of money.

 

 

CCK Consolidated

 

Cck Consolidated Holdings Bh (CCK) Snapshot

Open
0.87
 
Previous Close
0.87
Day High
0.87
 
Day Low
0.87
52 Week High
08/20/14 - 1.06
 
52 Week Low
12/26/14 - 0.80
Market Cap
135.1M
 
Average Volume 10 Days
46.4K
EPS TTM
0.06
 
Shares Outstanding
155.3M
EX-Date
05/28/14
 
P/E TM
14.7x
Dividend
0.02
 
Dividend Yield
1.72%
Current Stock Chart for CCK CONSOLIDATED HOLDINGS BH (CCK)
 
 
 

 

 

 

Sarawak based poultry company. Also owns 200 acres of fresh water prawn farm, with products mostly exported.

 

Quarter Result:

F.Y. Quarter Revenue ('000) Profit before Tax ('000) Profit Attb. to SH ('000) EPS (Cent) DPS (Cent) NAPS
2014-12-31 2014-09-30 122,805 3,127 2,343 1.51 - 0.9800
2014-12-31 2014-06-30 114,862 3,017 2,037 1.32 - 0.9600
2014-12-31 2014-03-31 117,335 4,162 3,107 2.01 - 0.9700
2013-12-31 2013-12-31 127,175 6,061 4,719 3.05 - 0.9500
2013-12-31 2013-09-30 119,772 6,410 4,553 2.94 - 0.9400
2013-06-30 2013-06-30 94,192 2,730 1,659 1.07 - 0.9100
2013-06-30 2013-03-31 94,583 2,402 1,475 0.95 - 0.9100
2013-06-30 2012-12-31 109,326 4,856 3,498 2.24 - -
2013-06-30 2012-09-30 110,669 6,121 4,421 2.82 - 0.9200
2012-06-30 2012-06-30 96,221 6,405 4,573 2.90 - -
2012-06-30 2012-03-31 98,710 6,392 4,638 2.94 - 0.8900
2012-06-30 2011-12-31 101,135 8,220 5,789 3.67 - 0.8700
2012-06-30 2011-09-30 114,832 8,179 5,544 3.52 - 0.8700
2011-06-30 2011-06-30 93,690 4,760 3,713 2.35 - -
2011-06-30 2011-03-31 94,831 5,060 3,701 2.35 - 0.8500
2011-06-30 2010-12-31 98,719 6,974 4,926 3.13 - 0.8300
2011-06-30 2010-09-30 104,739 8,745 6,048 3.84 - 0.8100
2010-06-30 2010-06-30 77,871 5,782 4,036 2.56 - -
2010-06-30 2010-03-31 88,127 5,081 3,707 2.35 - 0.7600
2010-06-30 2009-12-31 89,877 6,089 2,598 1.65 - 0.7600
2010-06-30 2009-09-30 95,336 7,406 5,034 3.19 - 0.7900
2009-06-30 2009-06-30 78,103 4,260 3,127 1.98 - -
2009-06-30 2009-03-31 80,765 4,954 3,471 2.20 - 0.7500

 

One thing that struck me immediately is how the group managed to report consistent earnings over the past. This is quite unusual for a poultry company.

 

The group has strong balance sheets with net gearing of 0.23 times only.

 

 

It seemed that apart from poultry farming, the retail division is also a major earning contributor (is this the reason behind the consistent earnings as mentioned above ?).

Prawn farming is not really profitable.

 

 

 

The group sells most of its products in Malaysia (Sarawak) but is expanding into Indonesia.

 

 

Comments

Good company. Consistent earnings but slow growth. At 14.7 times PER, fairly valued.

 

 

===========================================================================

 

CCM Duopharma Biotech

 

Ccm Duopharma Biotech Bhd (CCMD) Snapshot

Open
2.78
 
Previous Close
2.78
Day High
2.78
 
Day Low
2.78
52 Week High
08/26/14 - 3.37
 
52 Week Low
12/31/14 - 2.40
Market Cap
385.9M
 
Average Volume 10 Days
11.2K
EPS TTM
0.24
 
Shares Outstanding
138.8M
EX-Date
10/15/14
 
P/E TM
11.4x
Dividend
0.18
 
Dividend Yield
6.29%
Current Stock Chart for CCM DUOPHARMA BIOTECH BHD (CCMD)

 

 

 

 

 

 

 

 

 

 

 

CCM Duopharma Biotech Berhad, an investment holding company, manufactures, distributes, imports, and exports pharmaceutical products and medicines in Malaysia. 

 

 

 

 

 

Despite its name of "Biotech", it seemed that the group's products are quite basic (mouthwash, vitamin, eye drops, etc). However, this is not necessarily a bad thing. If the company is given preferential access by government hospitals, the supply of these basic items can provide a steady source of income.

 

CCM group is owned by PNB.

 

Quarter Result:
 

F.Y. Quarter Revenue ('000) Profit before Tax ('000) Profit Attb. to SH ('000) EPS (Cent) DPS (Cent) NAPS
2014-12-31 2014-09-30 44,819 11,287 8,682 6.25 - 1.3500
2014-12-31 2014-06-30 40,623 10,107 7,513 5.41 4.00 1.2900
2014-12-31 2014-03-31 40,495 11,175 8,365 6.03 - 1.3700
2013-12-31 2013-12-31 45,734 9,160 9,313 6.71 13.50 1.3100
2013-12-31 2013-09-30 40,845 9,054 6,786 4.89 - 1.2900
2013-12-31 2013-06-30 37,988 13,007 10,689 7.70 4.00 1.3500
2013-12-31 2013-03-31 37,837 8,956 6,699 4.83 - 1.2700
2012-12-31 2012-12-31 35,378 9,000 5,998 4.32 10.50 -
2012-12-31 2012-09-30 29,521 8,392 6,442 4.64 - 1.2100
2012-12-31 2012-06-30 34,355 9,037 6,867 4.95 3.50 1.1700
2012-12-31 2012-03-31 36,057 8,869 6,708 4.83 - 1.2300

 

As shown in table above, earnings are very consistent. Strong dividend yield of more than 6%. However, this is about to end soon....(please refer to details below regarding their corporate proposals)

 

Strong balance sheets with limited borrowings :-

 

 

 

In November 2014, the company announced that it has entered into agreements to acquire several companies from its parent company for cash consideration of RM133 mil and settlement of debt of RM118 mil.

 

The cash consideration is to be funded by a rights issue on the basis of 1 rights share for every share held. Share cap will increase by 100% post rights issue. Rights price yet to be fixed.

 

The settlement of RM118 mil debts will be funded by way of borrowings.

 

The acquiree companies are not profitable (collectively have net profit of RM1 mil only) but have manufacturing facilities that have spare capacity. The plan is for CCM Duopharma to make use of the facilities to increase its drugs production capacity (the company is also investing to expand existing capacity).

 

This is to capitalise on the impending "Patents Cliff" whereby many of the world's pahrmaceutical patents will expire over next few years and pharmaceutical companies can start producing generic version. The company expects government hospitals to start sourcing more from domestically produced drugs (following expiry of patents) and there will be higher demand for their products.

 

 

 

 

 

Comments

(a) Used to be a company with consistent earnings and high dividend yield.

(b) Recently announced acquisition of companies from parent company will result in significant dilution in EPS (as proceeds will be funded by rights issue and the target companies only generate agggregate net profit of RM1 mil, despite purchase price of RM133 mil).

(c) Long term prospects is good as additional capacity will drive growth in the future especially with the expiry of patents.

(d) For a normal company, this exercise shopuld have caused a massive derating of share price as the exercise will create an overhang. However, CCM Duopharma is tightly held and owned by powerful shareholders with abundant financial resources (to support share price, if necessary). So it is difficult to predict how the shares will perform in the short term and when is the best time to gain exposure.

(d) If you like the long term story, maybe the best timing to buy is now.

 

 

=================================================================================  

 

Chee Wah

 

Chee Wah Corp Bhd (CWAH) Snapshot

Open
0.40
 
Previous Close
0.40
Day High
0.40
 
Day Low
0.40
52 Week High
08/19/14 - 0.65
 
52 Week Low
03/13/14 - 0.38
Market Cap
16.8M
 
Average Volume 10 Days
2.5K
EPS TTM
0.0061
 
Shares Outstanding
42.1M
EX-Date
12/29/03
 
P/E TM
65.6x
Dividend
--
 
Dividend Yield
--
Current Stock Chart for CHEE WAH CORP BHD (CWAH)

 

 

 

 

 

 

 

 

 

 

 

 

The company only has market cap of RM16.8 mil. I believe this could be one of the smallest in Bursa.

 

 

 

Quarter Result:

F.Y. Quarter Revenue ('000) Profit before Tax ('000) Profit Attb. to SH ('000) EPS (Cent) DPS (Cent) NAPS
2015-06-30 2014-09-30 17,272 -450 -365 -0.87 - 0.9900
2014-06-30 2014-06-30 27,387 1,011 653 1.55 - 1.0000
2014-06-30 2014-03-31 15,570 -967 -854 -2.03 - 0.9900
2014-06-30 2013-12-31 27,110 921 827 1.96 - 1.0100
2014-06-30 2013-09-30 18,838 -599 -491 -1.17 - 0.9900
2013-06-30 2013-06-30 25,102 -177 -53 -0.13 - -
2013-06-30 2013-03-31 19,146 -884 -569 -1.35 - 1.0000
2013-06-30 2012-12-31 26,980 984 870 2.07 - 1.0100
2013-06-30 2012-09-30 14,966 -760 -599 -1.42 - 0.9900
2012-06-30 2012-06-30 24,760 -5,348 -6,001 -14.26 - -
2012-06-30 2012-03-31 16,299 -1,059 -837 -1.99 - 1.0200

 

The group has been loss making almost every quarter. However, this coming quarter result should show an improvement in earnings as the group exports 70% of its products :-

 

The group's gearing is quite high at 0.60 times. This is actually quite worrying as the group has not been very profitable. It will be difficult to pare down your borrowings when your operation is not generating surplus.

 

 

Comments

I am excited to discover Chee Wah as a currency play. However, the illiquidity of the shares made it very difficult to accumulate. The illiquidity could be dangerous in the event that the Ringgit starts strengthening as it will be difficult to exit. Will give it a pass.

 

Furthermore, weak currency is not a permanent feature. The group needs to be more efficient and not purely relies on weak currency to survive. 

 

==============================================================================

 

 

 

 

Related Stocks
Market Buzz
Discussions
2 people like this. Showing 2 of 2 comments

danchong

Thank for the detail write up on CCMDBIO. I do like the long the long term story and agree with your view. It needs very strong financial muscle & patient to hold on & see through the right issue exercise.

2015-02-09 22:57

jason

Possibly gearing up for the proposal of pharmacies dispensing medicine to patients ie doctors diagnose, pharmacists dispense system?

2015-02-18 09:56

Post a Comment